Belpharmax - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 12,000 | 8,000 | 9,000 | 17,500 | - | - | - | - |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 4,517 | 2 | 554 | 6,574 | 18,938 | 18,682 | 0 | 15,411 |
| Equity | -1,636 | -1,596 | -1,042 | 5,532 | 24,470 | 43,152 | 61,234 | 76,646 |
| Liabilities | 4,046 | 3,609 | 3,381 | 4,911 | 4,194 | 4,255 | 4,335 | 4,259 |
| Non-current assets | 861 | 861 | 861 | 861 | 861 | 861 | 861 | 859 |
| Current assets | 628 | 1,152 | 1,478 | 9,582 | 27,803 | 46,546 | 64,708 | 80,046 |
| Total assets | 1,489 | 2,013 | 2,339 | 10,443 | 28,664 | 47,407 | 65,569 | 80,905 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,830 | 5,909 | 6,265 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +200.0% | -33.3% | +12.5% | +94.4% | - | - | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 303.4% | 0.1% | 23.7% | 63.0% | 66.1% | 39.4% | 0.0% | 19.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 118.8% | 77.4% | 43.3% | 0.0% | 20.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 37.6% | 0.0% | 6.2% | 37.6% | - | - | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.9 | 0.2 | 0.1 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 6,000 | 4,000 | 4,500 | 8,750 | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Belpharmax - Social security debts
The company had no debts to Sodra
Belpharmax - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.